SELF-ADMINISTERED etripamil, an intranasal calcium channel blocker, significantly reduces emergency department (ED) visits ...

USA: A recent study published in JAMA Cardiology revealed that self-administered etripamil was almost twice as effective as ...

Milestone Pharmaceuticals MIST recently announced that the FDA has issued a Complete Response Letter (“CRL”) for its New Drug Application (“NDA”) seeking approval for CARDAMYST (etripamil) nasal spray ...

Ablation of supraventricular tachycardia in elderly persons presents a challenging problem to electrophysiologists. Friable cardiac structures, prone to catheter perforation, comorbid ...

Inappropriate sinus tachycardia, which is rare, occurs when the heart rate increases for no apparent reason. It could be the result of a nerve-signaling problem in the heart. Supraventricular ...

after the company announced receipt of a complete response letter from the FDA regarding its new drug application for its etripamil nasal spray for the treatment of paroxysmal supraventricular ...

The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.

An example of AVNRT tachycardia is shown in Figure 1. The P waves are hidden within the QRS complex, as this is a slow-fast type of reentry mechanism.